Article Complete
AIM
New AI model uncovers risk genes for motor neuron disease
New AI model uncovers risk genes for motor neuron disease

New AI model uncovers risk genes for motor neuron disease

Each new risk gene discovered is a potential target for the development of new treatments for MND.

Published Updated

Key takeaways

  • Researchers have developed RefMap, a machine learning tool that identifies risk genes for motor neurone disease.
  • The tool has discovered 690 risk genes, significantly increasing the understanding of the genetic basis of MND.
  • Each new risk gene presents a potential target for developing new treatments and facilitates genetic testing for families.
  • RefMap integrates genetic and epigenetic data and is being applied to other diseases in ongoing research.
  • Machine learning in genome analysis is revealing more hidden genes associated with complex diseases, leading to personalised treatment options.
5 min

Researchers from the University of Sheffield and the Stanford University School of Medicine have designed a machine learning tool to identify risk genes for motor neurone disease. The tool named RefMap, has already been utilised to discover 690 risk genes for motor neurone disease.

Dr Johnathan Cooper-Knock, from the University of Sheffield’s Neuroscience Institute, said: “This new tool will help us to understand and profile the genetic basis of MND. Using this model we have already seen a dramatic increase in the number of risk genes for MND, from approximately 15 to 690. Each new risk gene discovered is a potential target for the development of new treatments for MND and could also pave the way for genetic testing for families to work out their risk of disease.”

The 690 new genes identified by RefMap lead to a five-fold increase in discovered heritability, a measure which describes how much of the disease is due to a variation in genetic factors.

“RefMap identifies risk genes by integrating genetic and epigenetic data. It is a generic tool and we are applying it to more diseases in the lab,” Sai Zhang, PhD, instructor of genetics at the Stanford University School of Medicine said.

Michael Snyder, PhD, professor and chair of the department of genetics at the  Stanford School of Medicine and also the corresponding author of this work added: “By doing machine learning for genome analysis, we are discovering more hidden genes for human complex diseases such as MND, which will eventually power personalised treatment and intervention.”

Membership

Stay ahead with AI insights.

Unlimited access to premium articles, exclusive analysis, and the stories shaping India's AI economy.

Subscribe now

AIM Americas

1190 Miraloma Way Suite P, Sunnyvale, CA 94085

AIM India

1st Floor, Sakti Statesman, Bellandur, Bengaluru – 560103

Β© 2026 AIM. All rights reserved.